Musclepharm Corporation's ability to collect accounts receivable sequentially worsen to 7.01, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Musclepharm's Accounts Receivable average collection period in the Mar 31 2022 quarter, has increased to 52 days, from 46 days, in the Dec 31 2021 quarter.

If we take a look into Healthcare sector 271 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 2035.

What is Receivable Turnover Ratio?
What is Musclepharm Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MSLP Receivables Turnover Ratio	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter
Y / Y Receivable Change	49.12 %	-14.69 %	40.86 %	18.91 %	11.55 %
Y / Y Revenue Change	-0.15 %	-33.63 %	-25.58 %	-12.27 %	-19.16 %
Receivable Turnover Ratio (TTM)	7.01	7.85	8.29	9.68	10.4
MSLP's Total Ranking	# 2035	# 2035	# 32	# 32	# 34
Accounts Receivable average collection period days	52	47	44	38	35
Seq. Receivable Change	45.23 %	-12.88 %	31.78 %	-10.56 %	-16.92 %
Seq. Revenue Change	30.46 %	-16.11 %	-19.7 %	13.62 %	-13.28 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 100
Healthcare Sector	# 272
Overall Market	# 2035

Receivable Turnover Ratio Statistics
High	Average	Low
14.19	9.57	6.45
(Jun 30 2020)		(Sep 30 2018)

MSLP Company Profile • Back to MSLP Efficiency Comparisons • Compare MSLP Receivables Turnover Ratio to its Competitors

Financial Statements
Musclepharm's Accounts Receivable	$ 9 Millions	Visit MSLP's Balance sheet
Musclepharm's Sales TTM	$ 50 Millions	Visit MSLP's Income Statement
Sources of MSLP's Revenues		Visit MSLP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MSLP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MSLP's Growth Rates	MSLP's Roa	MSLP's Inventory Turnover Ratio	MSLP's Dividend Comparisons
MSLP's Profitability Ratios	MSLP's Roi	MSLP's Asset Turnover Ratio	MSLP's Dividend Growth
MSLP's Valuation Ratios	MSLP's Roe	MSLP's Financial Strength Ratios	MSLP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2022	Receivable at quarter ending Mar 31 2022
Ainos Inc	14.74	$ 0.680 Millions	$ 0.046 Millions
Patterson Companies Inc	14.69	$ 6,499.405 Millions	$ 442.413 Millions
Timber Pharmaceuticals Inc	14.64	$ 0.929 Millions	$ 0.063 Millions
Marinus Pharmaceuticals Inc	14.61	$ 27.725 Millions	$ 1.898 Millions
Genedx Holdings Corp	14.57	$ 313.151 Millions	$ 21.500 Millions
Viridian Therapeutics Inc	14.43	$ 1.728 Millions	$ 0.120 Millions
Corcept Therapeutics Inc	13.96	$ 380.229 Millions	$ 27.233 Millions
Myovant Sciences Ltd	13.52	$ 230.972 Millions	$ 17.087 Millions
Cv Sciences Inc	13.44	$ 19.651 Millions	$ 1.462 Millions
Bellicum Pharmaceuticals Inc	13.32	$ 6.236 Millions	$ 0.468 Millions
Precipio inc	13.23	$ 9.472 Millions	$ 0.716 Millions
Cartesian Therapeutics Inc	13.15	$ 108.026 Millions	$ 8.214 Millions
Biomerica Inc	12.97	$ 14.623 Millions	$ 1.128 Millions
Vireo Growth Inc.	12.94	$ 56.895 Millions	$ 4.396 Millions
Regenxbio Inc	12.64	$ 473.681 Millions	$ 37.468 Millions
Caremax Inc	12.46	$ 432.682 Millions	$ 34.718 Millions
Ultragenyx Pharmaceutical Inc	12.42	$ 331.946 Millions	$ 26.726 Millions
Inhibrx Biosciences Inc	12.42	$ 7.271 Millions	$ 0.586 Millions
Zomedica Corp	12.40	$ 3.704 Millions	$ 0.299 Millions
Merus N v	12.24	$ 52.412 Millions	$ 4.282 Millions
Semler Scientific inc	12.13	$ 53.860 Millions	$ 4.440 Millions
Celularity Inc	12.09	$ 24.610 Millions	$ 2.036 Millions
Clearside Biomedical Inc	11.96	$ 29.888 Millions	$ 2.500 Millions
Cano Health Inc	11.95	$ 2,033.571 Millions	$ 170.158 Millions
Clene Inc	11.68	$ 0.540 Millions	$ 0.046 Millions
Viveve Medical Inc	11.67	$ 6.617 Millions	$ 0.567 Millions
Finch Therapeutics Group Inc	11.54	$ 15.333 Millions	$ 1.329 Millions
Abiomed Inc	11.54	$ 1,031.753 Millions	$ 89.443 Millions
Longeveron Inc	11.50	$ 1.300 Millions	$ 0.113 Millions
Quanterix Corporation	11.40	$ 112.899 Millions	$ 9.904 Millions

Date modified: 2026-08-29T17:19:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.